{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T08:59:50Z","timestamp":1793177990786,"version":"4.5.0"},"reference-count":99,"publisher":"The Endocrine Society","issue":"11","license":[{"start":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T00:00:00Z","timestamp":1596844800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Anti-m\u00fcllerian hormone (AMH) is produced by granulosa cells of small, growing follicles in the ovary. Serum AMH levels strongly correlate with the number of growing follicles, and therefore AMH has received increasing attention as a marker for ovarian reserve. This review summarizes recent findings and limitations in the application of serum AMH in ovarian reserve assessment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Evidence Acquisition<\/jats:title>\n                    <jats:p>A PubMed search was conducted to find recent literature on the measurements and use of serum AMH as a marker for ovarian reserve.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Evidence Synthesis<\/jats:title>\n                    <jats:p>Serum AMH levels are measured to assess the \u201cfunctional ovarian reserve,\u201d a term that is preferred over \u201covarian reserve,\u201d since AMH levels reflect the pool of growing follicles that potentially can ovulate. Serum AMH levels are used in individualized follicle-stimulating hormone dosing protocols and may predict the risk of poor response or ovarian hyperstimulation syndrome but has limited value in predicting ongoing pregnancy. Serum AMH levels are studied to predict natural or disease-related age of menopause. Studies show that the age-dependent decline rates of AMH vary among women. The generalized implementation of serum AMH measurement has also led to an increase in diagnostic assays, including automated assays. However, direct comparison of results remains problematic.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Serum AMH remains the preferred ovarian reserve marker. However, the lack of an international standard for AMH limits comparison between AMH assays. Furthermore, little is known about endogenous and exogenous factors that influence serum AMH levels, which limits proper interpretation of AMH values in a clinical setting.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgaa513","type":"journal-article","created":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T15:46:26Z","timestamp":1596901586000},"page":"3361-3373","source":"Crossref","is-referenced-by-count":530,"title":["Anti-M\u00fcllerian Hormone and Ovarian Reserve: Update on Assessing Ovarian Function"],"prefix":"10.1210","volume":"105","author":[{"given":"Loes M E","family":"Moolhuijsen","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7182-3571","authenticated-orcid":false,"given":"Jenny A","family":"Visser","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2020,8,8]]},"reference":[{"issue":"8","key":"2021122106041051700_CIT0001","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/molehr\/gat024","article-title":"Which follicles make the most anti-mullerian hormone in humans? Evidence for an abrupt decline in AMH production at the time of follicle selection","volume":"19","author":"Jeppesen","year":"2013","journal-title":"Mol Hum Reprod."},{"issue":"1-2","key":"2021122106041051700_CIT0002","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0303-7207(98)00171-3","article-title":"Developmental and endocrine aspects of normal ovarian aging","volume":"145","author":"te Velde","year":"1998","journal-title":"Mol Cell Endocrinol."},{"issue":"3","key":"2021122106041051700_CIT0003","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/humupd\/dmt062","article-title":"The physiology and clinical utility of anti-mullerian hormone in women","volume":"20","author":"Dewailly","year":"2014","journal-title":"Hum Reprod Update."},{"key":"2021122106041051700_CIT0004","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1477-7827-9-23","article-title":"Defining ovarian reserve to better understand ovarian aging","volume":"9","author":"Gleicher","year":"2011","journal-title":"Reprod Biol Endocrinol."},{"issue":"3","key":"2021122106041051700_CIT0005","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.fertnstert.2014.10.037","article-title":"What is the \u201covarian reserve\u201d?","volume":"103","author":"Findlay","year":"2015","journal-title":"Fertil Steril."},{"issue":"7","key":"2021122106041051700_CIT0006","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1210\/en.2005-1588","article-title":"Serum anti-mullerian hormone levels reflect the size of the primordial follicle pool in mice","volume":"147","author":"Kevenaar","year":"2006","journal-title":"Endocrinology."},{"issue":"1","key":"2021122106041051700_CIT0007","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.fertnstert.2010.04.006","article-title":"Correlation of ovarian reserve tests with histologically determined primordial follicle number","volume":"95","author":"Hansen","year":"2011","journal-title":"Fertil Steril."},{"key":"2021122106041051700_CIT0008","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.maturitas.2020.02.001","article-title":"Serum anti-mullerian hormone (AMH) concentration has limited prognostic value for density of primordial and primary follicles, questioning it as an accurate parameter for the ovarian reserve","volume":"134","author":"von Wolff","year":"2020","journal-title":"Maturitas."},{"issue":"12","key":"2021122106041051700_CIT0009","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1093\/humrep\/dez215","article-title":"Serum anti-m\u00fcllerian hormone concentration and follicle density throughout reproductive life and in different diseases-implications in fertility preservation","volume":"34","author":"Liebenthron","year":"2019","journal-title":"Hum Reprod."},{"issue":"2","key":"2021122106041051700_CIT0010","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.fertnstert.2018.10.018","article-title":"Serum antim\u00fcllerian hormone is associated with the number of oocytes matured in vitro and with primordial follicle density in candidates for fertility preservation","volume":"111","author":"Sermondade","year":"2019","journal-title":"Fertil Steril."},{"issue":"7","key":"2021122106041051700_CIT0011","doi-asserted-by":"crossref","first-page":"e22024","DOI":"10.1371\/journal.pone.0022024","article-title":"A validated model of serum anti-m\u00fcllerian hormone from conception to menopause","volume":"6","author":"Kelsey","year":"2011","journal-title":"PLoS One."},{"issue":"12","key":"2021122106041051700_CIT0012","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1210\/jc.2012-1440","article-title":"Serum anti-m\u00fcllerian hormone levels in healthy females: a nomogram ranging from infancy to adulthood","volume":"97","author":"Lie Fong","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2021122106041051700_CIT0013","doi-asserted-by":"crossref","first-page":"e8772","DOI":"10.1371\/journal.pone.0008772","article-title":"Human ovarian reserve from conception to the menopause","volume":"5","author":"Wallace","year":"2010","journal-title":"PLoS One."},{"issue":"8","key":"2021122106041051700_CIT0014","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1177\/1933719115625843","article-title":"Age-specific normal reference range for serum anti-m\u00fcllerian hormone in healthy Chinese Han women: a nationwide population-based study","volume":"23","author":"Du","year":"2016","journal-title":"Reprod Sci."},{"issue":"12","key":"2021122106041051700_CIT0015","doi-asserted-by":"crossref","first-page":"777","DOI":"10.29252\/ijrm.14.12.777","article-title":"Age-specific nomograms for follicle stimulating hormone and anti-mullerian hormone: a pilot study in Ile-Ife, Nigeria","volume":"14","author":"Okunola","year":"2016","journal-title":"Int J Reprod Biomed (Yazd)."},{"issue":"5","key":"2021122106041051700_CIT0016","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3109\/13697137.2014.912262","article-title":"Age-specific serum anti-m\u00fcllerian hormone levels: estimates from a large population-based sample","volume":"17","author":"Tehrani","year":"2014","journal-title":"Climacteric."},{"issue":"2","key":"2021122106041051700_CIT0017","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.rbmo.2011.05.006","article-title":"External validation of nomogram for the decline in serum anti-m\u00fcllerian hormone in women: a population study of 15 834 infertility patients","volume":"23","author":"Nelson","year":"2011","journal-title":"Reprod Biomed Online."},{"key":"2021122106041051700_CIT0018","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.fertnstert.2010.08.022","article-title":"Nomogram for the decline in serum antimullerian hormone: a population study of 9601 infertility patients","volume":"95","author":"Nelson","year":"2011","journal-title":"Fertil Steril."},{"key":"2021122106041051700_CIT0019","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ejogrb.2016.09.013","article-title":"Age related normogram for antral follicle count in general population and comparison with previous studies","volume":"206","author":"Bozdag","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"issue":"12","key":"2021122106041051700_CIT0020","doi-asserted-by":"crossref","first-page":"e0189830","DOI":"10.1371\/journal.pone.0189830","article-title":"Age-related nomograms for antral follicle count and anti-mullerian hormone for subfertile Chinese women in Singapore","volume":"12","author":"Loy","year":"2017","journal-title":"PLoS One."},{"issue":"3","key":"2021122106041051700_CIT0021","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.rbmo.2019.11.013","article-title":"Ethnic discordance in serum anti-m\u00fcllerian hormone in healthy women: a population study from China and Europe","volume":"40","author":"Nelson","year":"2020","journal-title":"Reprod Biomed Online."},{"issue":"1","key":"2021122106041051700_CIT0022","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.fertnstert.2013.09.015","article-title":"Race\/ethnic disparities in reproductive age: an examination of ovarian reserve estimates across four race\/ethnic groups of healthy, regularly cycling women","volume":"101","author":"Bleil","year":"2014","journal-title":"Fertil Steril."},{"issue":"2","key":"2021122106041051700_CIT0023","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1093\/humrep\/der391","article-title":"Genetic variants and environmental factors associated with hormonal markers of ovarian reserve in Caucasian and African American women","volume":"27","author":"Schuh-Huerta","year":"2012","journal-title":"Hum Reprod."},{"issue":"7","key":"2021122106041051700_CIT0024","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1093\/humrep\/dem101","article-title":"Stable serum levels of anti-m\u00fcllerian hormone during the menstrual cycle: a prospective study in normo-ovulatory women","volume":"22","author":"Tsepelidis","year":"2007","journal-title":"Hum Reprod."},{"issue":"7","key":"2021122106041051700_CIT0025","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1055\/a-0840-3817","article-title":"Is there a need to alter the timing of anti-m\u00fcllerian hormone measurement during the menstrual cycle?","volume":"79","author":"Gorkem","year":"2019","journal-title":"Geburtshilfe Frauenheilkd."},{"key":"2021122106041051700_CIT0026","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.fertnstert.2015.09.033","article-title":"Levels of antimullerian hormone in serum during the normal menstrual cycle","volume":"105","author":"Lambert-Messerlian","year":"2016","journal-title":"Fertil Steril."},{"key":"2021122106041051700_CIT0027","doi-asserted-by":"crossref","first-page":"686","DOI":"10.3389\/fendo.2018.00686","article-title":"Anti-m\u00fcllerian hormone during natural cycle presents significant intra and intercycle variations when measured with fully automated assay","volume":"9","author":"Melado","year":"2018","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"6","key":"2021122106041051700_CIT0028","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.rbmo.2012.02.023","article-title":"Intra-cycle fluctuations of anti-m\u00fcllerian hormone in normal women with a regular cycle: a re-analysis","volume":"24","author":"Overbeek","year":"2012","journal-title":"Reprod Biomed Online."},{"key":"2021122106041051700_CIT0029","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3389\/fendo.2018.00603","article-title":"The impact of the biological variability or assay performance on AMH measurements: a prospective cohort study with AMH tested on three analytical assay-platforms","volume":"9","author":"Bungum","year":"2018","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"5","key":"2021122106041051700_CIT0030","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/0092-8674(86)90783-X","article-title":"Isolation of the bovine and human genes for m\u00fcllerian inhibiting substance and expression of the human gene in animal cells","volume":"45","author":"Cate","year":"1986","journal-title":"Cell."},{"issue":"35","key":"2021122106041051700_CIT0031","doi-asserted-by":"crossref","first-page":"18961","DOI":"10.1016\/S0021-9258(18)37375-7","article-title":"Proteolytic processing of mullerian inhibiting substance produces a transforming growth factor-beta-like fragment","volume":"263","author":"Pepinsky","year":"1988","journal-title":"J Biol Chem."},{"key":"2021122106041051700_CIT0032","doi-asserted-by":"crossref","first-page":"7711","DOI":"10.1073\/pnas.93.15.7711","article-title":"Bioactivation of mullerian inhibiting substance during gonadal development by a kex2\/subtilisin-like endoprotease","volume":"93","author":"Nachtigal","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2021122106041051700_CIT0033","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/mrd.1080320213","article-title":"M\u00fcllerian inhibiting substance in reproduction and cancer","volume":"32","author":"Donahoe","year":"1992","journal-title":"Mol Reprod Dev."},{"issue":"8","key":"2021122106041051700_CIT0034","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1515\/cclm-2014-0022","article-title":"First fully automated immunoassay for anti-m\u00fcllerian hormone","volume":"52","author":"Gassner","year":"2014","journal-title":"Clin Chem Lab Med."},{"key":"2021122106041051700_CIT0035","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12958-015-0101-5","article-title":"Comparison of two different methods for measuring anti-mullerian hormone in a clinical series","volume":"13","author":"Hyldgaard","year":"2015","journal-title":"Reprod Biol Endocrinol."},{"key":"2021122106041051700_CIT0036","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.fertnstert.2015.06.024","article-title":"Two new automated, compared with two enzyme-linked immunosorbent, antimullerian hormone assays","volume":"104","author":"Nelson","year":"2015","journal-title":"Fertil Steril"},{"key":"2021122106041051700_CIT0037","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12958-016-0143-3","article-title":"Assessment of the Access AMH assay as an automated, high-performance replacement for the AMH Generation II manual ELISA","volume":"14","author":"Pearson","year":"2016","journal-title":"Reprod Biol Endocrinol."},{"issue":"8","key":"2021122106041051700_CIT0038","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1093\/humrep\/dev127","article-title":"Performance of the two new fully automated anti-m\u00fcllerian hormone immunoassays compared with the clinical standard assay","volume":"30","author":"van Helden","year":"2015","journal-title":"Hum Reprod."},{"issue":"10","key":"2021122106041051700_CIT0039","doi-asserted-by":"crossref","first-page":"E1241","DOI":"10.1152\/ajpendo.00395.2013","article-title":"Human blood contains both the uncleaved precursor of anti-mullerian hormone and a complex of the NH2- and COOH-terminal peptides","volume":"305","author":"Pankhurst","year":"2013","journal-title":"Am J Physiol Endocrinol Metab."},{"issue":"11","key":"2021122106041051700_CIT0040","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1210\/me.2010-0273","article-title":"Processing of anti-mullerian hormone regulates receptor activation by a mechanism distinct from TGF-beta","volume":"24","author":"di Clemente","year":"2010","journal-title":"Mol Endocrinol."},{"key":"2021122106041051700_CIT0041","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.fertnstert.2019.03.002","article-title":"Associations of different molecular forms of antimullerian hormone and biomarkers of polycystic ovary syndrome and normal women","volume":"112","author":"Wissing","year":"2019","journal-title":"Fertil Steril"},{"issue":"1","key":"2021122106041051700_CIT0042","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1089\/jwh.2019.7733","article-title":"Assessment of circulating anti-m\u00fcllerian hormone in women using hormonal contraception: a systematic review","volume":"29","author":"Amer","year":"2020","journal-title":"J Womens Health (Larchmt)."},{"issue":"1","key":"2021122106041051700_CIT0043","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/13625187.2019.1702158","article-title":"Ovarian reserve markers in women using various hormonal contraceptives","volume":"25","author":"Landersoe","year":"2020","journal-title":"Eur J Contracept Reprod Health Care."},{"issue":"9","key":"2021122106041051700_CIT0044","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1097\/GME.0000000000001116","article-title":"Is ovarian reserve associated with body mass index and obesity in reproductive aged women? A meta-analysis","volume":"25","author":"Moslehi","year":"2018","journal-title":"Menopause."},{"issue":"6","key":"2021122106041051700_CIT0045","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1093\/humrep\/det072","article-title":"Leptin suppresses anti-mullerian hormone gene expression through the JAK2\/STAT3 pathway in luteinized granulosa cells of women undergoing IVF","volume":"28","author":"Merhi","year":"2013","journal-title":"Hum Reprod."},{"key":"2021122106041051700_CIT0046","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.gene.2017.08.028","article-title":"Leptin siRNA promotes ovarian granulosa cell apoptosis and affects steroidogenesis by increasing NPY2 receptor expression","volume":"633","author":"Ding","year":"2017","journal-title":"Gene."},{"issue":"7","key":"2021122106041051700_CIT0047","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1210\/jc.2012-1213","article-title":"The level of serum anti-m\u00fcllerian hormone correlates with vitamin D status in men and women but not in boys","volume":"97","author":"Dennis","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"key":"2021122106041051700_CIT0048","doi-asserted-by":"crossref","DOI":"10.3390\/nu9070719","article-title":"Acute supplementation with high dose vitamin D3 increases serum anti-mullerian hormone in young women","volume":"9","author":"Dennis","year":"2017","journal-title":"Nutrients"},{"key":"2021122106041051700_CIT0049","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.fertnstert.2016.08.037","article-title":"Direct vitamin D3 actions on rhesus macaque follicles in three-dimensional culture: assessment of follicle survival, growth, steroid, and antimullerian hormone production","volume":"106","author":"Xu","year":"2016","journal-title":"Fertil Steril"},{"key":"2021122106041051700_CIT0050","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.3389\/fphys.2018.01600","article-title":"Vitamin D3 regulates follicular development and intrafollicular vitamin D biosynthesis and signaling in the primate ovary","volume":"9","author":"Xu","year":"2018","journal-title":"Front Physiol."},{"issue":"6","key":"2021122106041051700_CIT0051","doi-asserted-by":"crossref","first-page":"E1137","DOI":"10.1210\/jc.2013-4161","article-title":"Vitamin D alters genes involved in follicular development and steroidogenesis in human cumulus granulosa cells","volume":"99","author":"Merhi","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"issue":"3-5","key":"2021122106041051700_CIT0052","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.jsbmb.2006.12.051","article-title":"Novel pathways that contribute to the anti-proliferative and chemopreventive activities of calcitriol in prostate cancer","volume":"103","author":"Krishnan","year":"2007","journal-title":"J Steroid Biochem Mol Biol."},{"issue":"4","key":"2021122106041051700_CIT0053","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000323142","article-title":"Delayed childbearing: effects on fertility and the outcome of pregnancy","volume":"29","author":"Balasch","year":"2011","journal-title":"Fetal Diagn Ther."},{"key":"2021122106041051700_CIT0054","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2018-00724","article-title":"Does AMH relate to timing of menopause? Results of an individual patient data meta- analysis","author":"Depmann","year":"2018","journal-title":"J Clin Endocrinol Metab."},{"key":"2021122106041051700_CIT0055","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.maturitas.2017.04.018","article-title":"Anti-m\u00fcllerian hormone, follicle stimulating hormone, antral follicle count, and risk of menopause within 5 years","volume":"102","author":"Kim","year":"2017","journal-title":"Maturitas."},{"key":"2021122106041051700_CIT0056","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz283","article-title":"Antimullerian hormone and impending menopause in late reproductive age: the study of women\u2019s health across the nation","volume":"105","author":"Finkelstein","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2021122106041051700_CIT0057","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1093\/humrep\/dey077","article-title":"Anti-m\u00fcllerian hormone levels and incidence of early natural menopause in a prospective study","volume":"33","author":"Bertone-Johnson","year":"2018","journal-title":"Hum Reprod."},{"issue":"1","key":"2021122106041051700_CIT0058","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12916-016-0699-y","article-title":"Back to the basics of ovarian aging: a population-based study on longitudinal anti-m\u00fcllerian hormone decline","volume":"14","author":"de Kat","year":"2016","journal-title":"BMC Med."},{"issue":"11","key":"2021122106041051700_CIT0059","doi-asserted-by":"crossref","first-page":"5024","DOI":"10.1210\/jc.2018-02607","article-title":"Can menopause prediction be improved with multiple AMH measurements? Results from the prospective Doetinchem cohort study","volume":"104","author":"de Kat","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"key":"2021122106041051700_CIT0060","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa083","article-title":"Improving prediction of age at menopause using multiple anti-mullerian hormone measurements: the Tehran lipid-glucose study","volume":"105","author":"Ramezani Tehrani","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2021122106041051700_CIT0061","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/GME.0000000000000642","article-title":"Individualized predictions of time to menopause using multiple measurements of antim\u00fcllerian hormone","volume":"23","author":"Gohari","year":"2016","journal-title":"Menopause."},{"issue":"4","key":"2021122106041051700_CIT0062","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.rbmo.2017.01.010","article-title":"Ovarian stimulation protocols for IVF: is more better than less?","volume":"34","author":"Alper","year":"2017","journal-title":"Reprod Biomed Online."},{"key":"2021122106041051700_CIT0063","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.fertnstert.2013.04.024","article-title":"Prediction of an excessive response in in vitro fertilization from patient characteristics and ovarian reserve tests and comparison in subgroups: an individual patient data meta-analysis","volume":"100","author":"Broer","year":"2013","journal-title":"Fertil Steril."},{"issue":"1","key":"2021122106041051700_CIT0064","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/humupd\/dms041","article-title":"Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach","volume":"19","author":"Broer","year":"2013","journal-title":"Hum Reprod Update."},{"key":"2021122106041051700_CIT0065","first-page":"CD012693","article-title":"Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF\/ICSI)","volume":"2","author":"Lensen","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"2021122106041051700_CIT0066","doi-asserted-by":"crossref","first-page":"hoz003","DOI":"10.1093\/hropen\/hoz003","article-title":"A randomized controlled trial of AMH-based individualized FSH dosing in a GnRH antagonist protocol for IVF","volume":"2019","author":"Friis Petersen","year":"2019","journal-title":"Hum Reprod Open"},{"issue":"2","key":"2021122106041051700_CIT0067","doi-asserted-by":"crossref","first-page":"207","DOI":"10.21037\/apm.2020.02.11","article-title":"Assessment of ovarian reserve by serum anti-m\u00fcllerian hormone in patients with systemic lupus erythematosus: a meta-analysis","volume":"9","author":"Luo","year":"2020","journal-title":"Ann Palliat Med."},{"issue":"9","key":"2021122106041051700_CIT0068","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1002\/acr.22013","article-title":"Levels of serum anti-m\u00fcllerian hormone, a marker for ovarian reserve, in women with rheumatoid arthritis","volume":"65","author":"Brouwer","year":"2013","journal-title":"Arthritis Care Res (Hoboken)."},{"issue":"9","key":"2021122106041051700_CIT0069","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1093\/rheumatology\/kev124","article-title":"Ovarian reserve alterations in premenopausal women with chronic inflammatory rheumatic diseases: impact of rheumatoid arthritis, Beh\u00e7et\u2019s disease and spondyloarthritis on anti-m\u00fcllerian hormone levels","volume":"54","author":"Henes","year":"2015","journal-title":"Rheumatology (Oxford)."},{"issue":"5","key":"2021122106041051700_CIT0070","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3899\/jrheum.180176","article-title":"Fertility and ovarian reserve among women with rheumatoid arthritis","volume":"46","author":"Eudy","year":"2019","journal-title":"J Rheumatol."},{"issue":"3","key":"2021122106041051700_CIT0071","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1080\/14397595.2018.1465646","article-title":"Ovarian reserve in young juvenile idiopathic arthritis patients","volume":"29","author":"Ferreira","year":"2019","journal-title":"Mod Rheumatol."},{"key":"2021122106041051700_CIT0072","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ejogrb.2016.06.002","article-title":"Serum anti-m\u00fcllerian hormone levels in euthyroid adolescent girls with Hashimoto\u2019s thyroiditis: relationship to antioxidant status","volume":"203","author":"Erol","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"issue":"4","key":"2021122106041051700_CIT0073","first-page":"331","article-title":"Evaluation of the ovarian reserve in adolescents with Hashimoto\u2019s thyroiditis using serum anti-m\u00fcllerian hormone levels","volume":"10","author":"\u00d6zalp Ak\u0131n","year":"2018","journal-title":"J Clin Res Pediatr Endocrinol."},{"issue":"4","key":"2021122106041051700_CIT0074","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3109\/09513590.2015.1116510","article-title":"Assessment of ovarian reserve in euthyroid adolescents with Hashimoto thyroiditis","volume":"32","author":"Pirgon","year":"2016","journal-title":"Gynecol Endocrinol."},{"issue":"10","key":"2021122106041051700_CIT0075","doi-asserted-by":"crossref","first-page":"708","DOI":"10.3109\/09513590.2014.926324","article-title":"Evaluation of ovarian reserve in Hashimoto\u2019s thyroiditis","volume":"30","author":"Tuten","year":"2014","journal-title":"Gynecol Endocrinol."},{"issue":"2","key":"2021122106041051700_CIT0076","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10815-014-0397-7","article-title":"Elevated serum thyroid-stimulating hormone is associated with decreased anti-m\u00fcllerian hormone in infertile women of reproductive age","volume":"32","author":"Kuroda","year":"2015","journal-title":"J Assist Reprod Genet."},{"issue":"1","key":"2021122106041051700_CIT0077","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12958-016-0162-0","article-title":"What affects functional ovarian reserve, thyroid function or thyroid autoimmunity?","volume":"14","author":"Weghofer","year":"2016","journal-title":"Reprod Biol Endocrinol."},{"issue":"1","key":"2021122106041051700_CIT0078","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12902-019-0370-7","article-title":"Overtime trend of thyroid hormones and thyroid autoimmunity and ovarian reserve: a longitudinal population study with a 12-year follow up","volume":"19","author":"Bahri","year":"2019","journal-title":"BMC Endocr Disord."},{"issue":"9","key":"2021122106041051700_CIT0079","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1089\/thy.2017.0139","article-title":"Idiopathic low ovarian reserve is associated with more frequent positive thyroid peroxidase antibodies","volume":"27","author":"Chen","year":"2017","journal-title":"Thyroid."},{"issue":"1","key":"2021122106041051700_CIT0080","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1089\/thy.2019.0031","article-title":"Subclinical hypothyroidism is associated with lower ovarian reserve in women aged 35 years or older","volume":"30","author":"Rao","year":"2020","journal-title":"Thyroid."},{"issue":"4","key":"2021122106041051700_CIT0081","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/jog.13554","article-title":"Levothyroxine supplementation improves serum anti-m\u00fcllerian hormone levels in infertile patients with Hashimoto\u2019s thyroiditis","volume":"44","author":"Kuroda","year":"2018","journal-title":"J Obstet Gynaecol Res."},{"issue":"1","key":"2021122106041051700_CIT0082","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12958-015-0103-3","article-title":"Anti-mullerian hormone as a predictor of ovarian reserve in ART protocols: the hidden role of thyroid autoimmunity","volume":"13","author":"Magri","year":"2015","journal-title":"Reprod Biol Endocrinol."},{"issue":"8","key":"2021122106041051700_CIT0083","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.2337\/diabetes.50.8.1857","article-title":"Menopause in type 1 diabetic women: is it premature?","volume":"50","author":"Dorman","year":"2001","journal-title":"Diabetes."},{"issue":"11","key":"2021122106041051700_CIT0084","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1093\/humrep\/dep276","article-title":"Anti-mullerian hormone and inhibin B levels as markers of premature ovarian aging and transition to menopause in type 1 diabetes mellitus","volume":"24","author":"Soto","year":"2009","journal-title":"Hum Reprod."},{"issue":"6","key":"2021122106041051700_CIT0085","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.fertnstert.2016.07.009","article-title":"Antim\u00fcllerian hormone among women with and without type 1 diabetes: the epidemiology of diabetes interventions and complications study and the Michigan Bone Health and Metabolism Study","volume":"106","author":"Kim","year":"2016","journal-title":"Fertil Steril."},{"issue":"6","key":"2021122106041051700_CIT0086","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1093\/humrep\/dew063","article-title":"Association between vascular health and ovarian ageing in type 1 diabetes mellitus","volume":"31","author":"Yarde","year":"2016","journal-title":"Hum Reprod."},{"issue":"2","key":"2021122106041051700_CIT0087","first-page":"441","article-title":"Age at menopause in women with type 1 diabetes mellitus: the OVADIA study","volume":"30","author":"Yarde","year":"2015","journal-title":"Hum Reprod."},{"issue":"18","key":"2021122106041051700_CIT0088","doi-asserted-by":"crossref","first-page":"4278","DOI":"10.7150\/jca.31859","article-title":"GnRHa for ovarian protection and the association between AMH and ovarian function during adjuvant chemotherapy for breast cancer","volume":"10","author":"Zhong","year":"2019","journal-title":"J Cancer."},{"key":"2021122106041051700_CIT0089","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ejca.2017.10.001","article-title":"The utility of anti-m\u00fcllerian hormone in the diagnosis and prediction of loss of ovarian function following chemotherapy for early breast cancer","volume":"87","author":"Anderson","year":"2017","journal-title":"Eur J Cancer."},{"issue":"3","key":"2021122106041051700_CIT0090","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s10549-018-4997-2","article-title":"Pretreatment anti-mullerian hormone-based nomogram predicts menstruation status after chemotherapy for premenopausal women with hormone receptor-positive early breast cancer","volume":"173","author":"Xue","year":"2019","journal-title":"Breast Cancer Res Treat."},{"issue":"1","key":"2021122106041051700_CIT0091","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1016\/j.clbc.2018.10.003","article-title":"Impact of chemotherapy-induced menopause in women of childbearing age with non-metastatic breast cancer - preliminary results from the MENOCOR study","volume":"19","author":"Passildas","year":"2019","journal-title":"Clin Breast Cancer."},{"issue":"3","key":"2021122106041051700_CIT0092","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s10549-018-4863-2","article-title":"Prediction of ovarian function recovery in young breast cancer patients after protection with gonadotropin-releasing hormone agonist during chemotherapy","volume":"171","author":"Lee","year":"2018","journal-title":"Breast Cancer Res Treat."},{"issue":"6","key":"2021122106041051700_CIT0093","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.rbmo.2018.02.004","article-title":"Different patterns of ovarian recovery after cancer treatment suggest various individual ovarian susceptibilities to chemotherapy","volume":"36","author":"Decanter","year":"2018","journal-title":"Reprod Biomed Online."},{"issue":"8","key":"2021122106041051700_CIT0094","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1530\/EC-18-0180","article-title":"Post-chemotherapy serum anti-m\u00fcllerian hormone level predicts ovarian function recovery","volume":"7","author":"Kim","year":"2018","journal-title":"Endocr Connect."},{"issue":"5","key":"2021122106041051700_CIT0095","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1210\/jc.2018-02257","article-title":"Differential rates of change in measures of ovarian reserve in young cancer survivors across the reproductive lifespan","volume":"104","author":"Cameron","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"key":"2021122106041051700_CIT0096","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa172","article-title":"Modeling variation in the reproductive lifespan of female adolescent and young adult cancer survivors using AMH","author":"Su","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2021122106041051700_CIT0097","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1089\/thy.2017.0442","article-title":"A single radioactive iodine treatment has a deleterious effect on ovarian reserve in women with thyroid cancer: results of a prospective pilot study","volume":"28","author":"Yaish","year":"2018","journal-title":"Thyroid."},{"issue":"12","key":"2021122106041051700_CIT0098","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1089\/thy.2018.0129","article-title":"Effects of radioactive iodine therapy on ovarian reserve: a prospective pilot study","volume":"28","author":"Evranos","year":"2018","journal-title":"Thyroid."},{"issue":"4","key":"2021122106041051700_CIT0099","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1089\/thy.2019.0504","article-title":"Longitudinal analysis of the effect of radioiodine therapy on ovarian reserve in females with differentiated thyroid cancer","volume":"30","author":"van Velsen","year":"2020","journal-title":"Thyroid."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaa513\/33619564\/dgaa513.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/105\/11\/3361\/41828005\/dgaa513.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/105\/11\/3361\/41828005\/dgaa513.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T01:05:49Z","timestamp":1640048749000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/105\/11\/3361\/5890022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,8]]},"references-count":99,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,8,8]]},"published-print":{"date-parts":[[2020,11,1]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaa513","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,11]]},"published":{"date-parts":[[2020,8,8]]}}}